Wang Xiaolin
- SEC CIK
- 0001849181
In the past year, 1 open-market sale filing worth $200.0K and no purchases.
Current role at each company
- RVMD Revolution Medicines, Inc.See Remarksas of Mar 19, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $200.0K
- 1 filing
- Net
- −$200.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wang Xiaolin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 (view filing) | Mar 17 | 2 days | Wang XiaolinSee Remarks | SSale | −2.01K | $99.48 | −$200.0K | −1.7%116.1K after | 10b5-1 |
| Mar 21, 2023 (view filing) | Mar 17 | 4 days | Wang XiaolinSee Remarks | SSale | −714 | $21.78 | −$15.6K | −1.2%58.8K after | |
| Dec 21, 2022 (view filing) | Dec 19 | 2 days | Wang XiaolinSee Remarks | SSale | −708 | $22.94 | −$16.2K | −2.3%30.5K after | |
| Sep 21, 2022 (view filing) | Sep 19 | 2 days | Wang XiaolinSee Remarks | SSale | −735 | $19.04 | −$14.0K | −2.3%31.2K after | |
| Jun 22, 2022 (view filing) | Jun 17 | 5 days | Wang XiaolinSee Remarks | SSale | −665 | $17.75 | −$11.8K | −2.0%32.0K after | |
| Mar 21, 2022 (view filing) | Mar 17 | 4 days | Wang XiaolinSee Remarks | SSale | −240 | $18.61 | −$4.47K | −0.8%31.7K after | |
| Dec 21, 2021 (view filing) | Dec 17 | 4 days | Wang XiaolinSee Remarks | SSale | −257 | $24.41 | −$6.27K | −2.1%11.9K after | |
| Sep 21, 2021 (view filing) | Sep 17 | 4 days | Wang XiaolinSee Remarks | SSale | −250 | $30.02 | −$7.50K | −2.0%12.2K after |